National Association of Testing Authorities, Australia
Scope of Accreditation
Australian Clinical Labs
Site
Geelong Laboratory
Accreditation No.
3427
Site No.
2262
Date of Accreditation
30 Nov 1987
Contact
Availability
Services available to external clients
Supervision
GY (General)
Scope of Accreditation
Geelong Laboratory
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
02 Jan 2026
Last Activity Date
25 Jul 2024
| Service | Product | Determinant |
|---|---|---|
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of body fluids, exudates, washings and brushings from non-squamous mucosal sites for the detection of malignancy | Other body fluids; Sputum; Urine | Cytological examination; Review and reporting of cytology samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations on samples obtained via fine needle aspiration biopsy | Fine needle aspirates (FNA) | Cytological examination; Review and reporting of fine needle aspiration samples |
| Anatomical pathology - Tissue pathology - Examination of biopsy material | Formalin-fixed tissue | Review and reporting of biopsy material to identify or exclude morphological abnormalities |
| Anatomical pathology - Tissue pathology - Immediate frozen section diagnosis | Fresh tissue | Intra-operative consultation and examination of biopsy material |
| Anatomical pathology - Tissue pathology - Immunohistochemical (immunofluorescence) investigation | Formalin-fixed paraffin-embedded (FFPE) tissues; Fresh tissue; Frozen tissue | Detection of antigenic targets - Various |
| Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Blood; Snake bite site; Urine | Snake venom detection |
| Plasma; Urine | Ethanol | |
| Urine | Amphetamines; Barbiturates; Benzodiazepines; Cannabis; Cocaine; Methadone; Opiates | |
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Blood | Cyclosporin; Methotrexate; Tacrolimus |
| Plasma; Serum | Carbamazepine; Digoxin; Gentamicin (cidomycin, septopal, genticyn, garamycin); Lithium; Methotrexate; Paracetamol (acetaminophen); Phenobarbitone; Phenytoin (dilantin); Salicylate; Theophylline; Tobramycin; Valproate (valproic acid, epilim); Vancomycin | |
| Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Plasma; Serum | Cortisol; Follicle stimulating hormone (FSH); Oestradiol; Parathyroid hormone (PTH); Progesterone; Prolactin |
| Chemical pathology - Further investigation of cardiac function | Plasma; Serum | Troponin I |
| Chemical pathology - Further investigation of lipid profiles for diagnosis of types III and IV hyperlipidaemia | Plasma; Serum | HDL - Quantitation |
| Chemical pathology - Further investigation of renal and/or hepatic function | Other body fluids; Plasma; Serum; Urine | Uric acid |
| Chemical pathology - Haem related pigments and precursors (excluding porphyria) | Plasma; Serum | Haptoglobins |
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Cerebrospinal fluid (CSF) | Glucose; Lactate; Protein - Total |
| Plasma; Serum | Alanine aminotransferase; Albumin; Alkaline phosphatase; Ammonia; Amylase; Aspartate aminotransferase; Bicarbonate; Bilirubin - Any fractions; Bilirubin - Total; C-reactive protein (CRP); Calcium - Total; Carbon dioxide (CO2); Chloride; Cholesterol - Total; Creatine kinase; Creatinine; Glucose; Lactate; Lactate dehydrogenase (LDH); Lipase; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Triglycerides; Urate; Urea; γ-Glutamyltransferase | |
| Plasma; Serum; Urine | Osmolality | |
| Urine | Amylase; Calcium - Total; Chloride; Creatinine; Glucose; Magnesium; Microalbumin; Phosphate; Potassium; Protein - Total; Sodium; Urea | |
| Chemical pathology - Iron studies | Plasma; Serum | Ferritin; Iron; Transferrin |
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
| Chemical pathology - Tests for thyroid function | Plasma; Serum | Thyroxine (T4) - Total |
| Thyroid stimulating hormone (TSH); Thyroxine (T4) - Free | ||
| Triiodothyronine (T3) - Free | ||
| Haematology - Bone marrow examination | Bone marrow | Examination of aspirated material; Histological examination |
| Haematology - Examination of blood films by special staining | Blood | Malaria |
| Bone marrow | Iron | |
| Haematology - Foetal haemoglobin in maternal circulation | Blood | Detection and quantitation of foetal red cell antigens |
| Presence of foetal red blood cells | ||
| Haematology - Full blood examination | Blood | Differential number; Erythrocyte count (red blood cell count, RBCC); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Platelet count; Red blood cell index or indices; Reticulocytes |
| Differential number; Morphology | ||
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Plasma | Activated partial thromboplastin time (APTT); Anti-Xa activity; D-dimer; Factor IX; Factor VIII; Fibrinogen; International normalised ratio (INR); Thrombin time (TT) |
| Haematology - Limited blood examination | Blood | Erythrocyte (RBC) sedimentation rate (ESR) |
| Immunohaematology - Blood group antibody detection | Blood; Plasma | Duffy system; Kell system; M and N factors; Other blood group systems; Rh phenotypes |
| Immunohaematology - Blood grouping | Blood | ABO; RhD |
| Immunohaematology - Determination of compatibility of blood donor units | Blood | Direct antiglobulin test (DAT, direct Coombs test); Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies |
| Immunohaematology - Identification and quantitation of blood group antibodies | Blood | Other blood group antibodies; Red blood cell phenotyping; Rh |
| Antibody absorption | ||
| Antibody elution | ||
| Antibody titration | ||
| Immunohaematology - Investigation of blood transfusion reactions | Blood products | Antibodies |
| Immunohaematology - Issue and release of blood and blood product for transfusion | Blood; Blood products; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
| Immunohaematology - Storage and distribution of blood and blood components | Blood; Blood products; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
| Immunopathology - Characterisation of leucocyte surface antigens (including immunophenotyping) | Blood | CD10; CD103; CD117; CD11b; CD11c; CD13; CD138; CD14; CD15; CD16; CD19; CD1a; CD2; CD20; CD200; CD22; CD23; CD25; CD3; CD33; CD34; CD38; CD4; CD45; CD5; CD56; CD57; CD61; CD64; CD7; CD71; CD79b; CD8; FMC7; HLA-DR antigen; Kappa light chains; Lambda light chains; Myeloperoxidase; Natural killer (NK) cells; Terminal deoxynucleotidyl transferase (TdT) |
| Immunopathology - Tests of cellular immunity - Lymphocyte function tests | Blood | Lymphocyte quantitation; T-cell subsets; T-lymphocyte, B-lymphocyte and natural killer (TBNK) |
| Infertility and pregnancy tests including assisted reproductive technology - Diagnosis or follow up of threatened abortion and/or diagnosis of ectopic pregnancy | Plasma; Serum | Human chorionic gonadotropin (hCG) - Quantitative total |
| Infertility and pregnancy tests including assisted reproductive technology - Semen analysis (other than post vasectomy) | Semen | Motility |
| Infertility and pregnancy tests including assisted reproductive technology - Semen analysis for post vasectomy and/or examination of cervical mucus | Semen | Presence of spermatozoa |
| Microbiology - Bacteriology - Detection and identification of crystalline material | Synovial fluid | Crystal detection and identification |
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Bacterial isolates | Pathogenic identification |
| Pathogenic identification | ||
| Antibiotic susceptibility | ||
| Antibiotic susceptibility | ||
| Pathogenic identification | ||
| Blood | Bacteria; Pathogenic microorganisms | |
| Cerebrospinal fluid (CSF); Faeces; Fluids; General swabs; Genital swabs; Respiratory specimens; Tissues; Urine | Bacteria; Pathogenic microorganisms | |
| Cerebrospinal fluid (CSF); Fluids; General swabs; Genital swabs; Respiratory specimens; Tissues | Bacteria; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | |
| Faeces | Clostridioides difficile toxin; Clostridium difficile glutamate dehydrogenase | |
| Urine | Bacteria; Blood; Casts; Crystals; Epithelial cells; Erythrocytes (red blood cells, RBC); Glucose; Leucocytes (white blood cells, WBC); Proteins; Specific gravity; pH | |
| Legionella antigen; Streptococcus pneumoniae antigen | ||
| Blood; Glucose; Proteins; pH | ||
| Bacteria; Casts; Crystals; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | ||
| Blood; Glucose; Proteins; pH | ||
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Faeces | Clostridioides difficile |
| Nasopharyngeal aspirate; Nasopharyngeal swabs | Bordetella pertussis; Mycoplasma pneumoniae | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Nasopharyngeal aspirate; Nasopharyngeal swabs | Adenovirus; Enterovirus; Human coronavirus NL63; Human coronavirus 229E; Human coronavirus HKU1; Human coronavirus OC43; Human metapneumovirus; Influenza A virus; Influenza B virus; Parainfluenza virus; Respiratory syncytial virus (RSV); Rhinovirus; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) |
| Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Microbiology - Mycobacteriology - Detection and identification of mycobacteria | Cerebrospinal fluid (CSF); Isolates; Respiratory specimens; Sputum; Tissues | Mycobacteria detection |
| Cerebrospinal fluid (CSF); Respiratory specimens; Sputum; Tissues | Culture and limited identification | |
| Mycobacteria identification | ||
| Isolates | Mycobacteria identification; Other pathogenic bacteria to genus level or species level | |
| Urine | Mycobacteria identification | |
| Microbiology - Mycology - Detection, isolation and/or identification of yeasts and/or fungal elements | Cerebrospinal fluid (CSF); Fluids; General swabs; Genital swabs; Respiratory specimens; Respiratory swabs; Tissues; Urine | Yeasts identification |
| Cerebrospinal fluid (CSF); Serum | Cryptococcus antigen | |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Blood | Malaria |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Plasma; Serum | Infectious mononucleosis |
| Serum | Human immunodeficiency virus (HIV) |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
3427
Site No.
2262
Print date
15 Jan 2025
END OF SCOPE